iridium radioisotopes has been researched along with Adenocarcinoma in 90 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 12 (13.33) | 18.7374 |
1990's | 39 (43.33) | 18.2507 |
2000's | 26 (28.89) | 29.6817 |
2010's | 13 (14.44) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ben Mrad, M; Chauleur, C; de Laroche, G; Espenel, S; Garcia, MA; Guy, JB; Langrand-Escure, J; Magné, N; Moreno-Acosta, P; Rancoule, C; Trone, JC; Vallard, A | 1 |
Zhang, H; Zhang, WH; Zhu, YL | 1 |
Barbet, N; Benezery, K; Chapet, O; Coquard, R; Doyen, J; François, E; Frin, AC; Gal, J; Gerard, JP; Marcié, S; Romestaing, P; Zhou, FX | 1 |
Garmash, SV; Isaev, TK; Kravtsov, IB; Panshin, GA; Pavlov, AY; Solodky, VA; Tsybulsky, AD | 1 |
Collettini, F; Gebauer, B; Hamm, B; Riess, H; Schippers, AC; Schnapauff, D; Wieners, G; Wust, P | 1 |
Aguayo, M; Andrés, I; Arenas, M; Berenguer, R; Camacho-Lopez, C; Gascon, M; Rovirosa, A; Sabater, S; Sevillano, M; Villas, MV | 1 |
Gustafson, GS; Krauss, DJ; Limbacher, A; Martinez, AA; Mitchell, B; Sebastian, E; Ye, H | 1 |
Battermann, JJ; Bosch, JL; Kok, ET; Oddens, JR; van Moorselaar, RJ; van Onna, IE | 1 |
Li, HP; Li, LY; Luo, B; Pan, M; Shu, KY; Zeng, SY | 1 |
Chang, WC; Chen, SW; Hung, YC; Liang, JA; Lin, FJ; Yang, SN; Yeh, LS | 1 |
Chen, HC; Fang, FM; Hsu, HC; Huang, EY; Huang, YJ; Lan, JH; Wang, CJ; Wang, CY; Wang, YM | 1 |
Guo, WB; Huang, YH; Li, HP; Tan, GS; Xiang, XH; Yang, JY; Yu, L | 1 |
Bai, P; Li, W; Ma, Y; Zhang, R | 1 |
Kamada, T; Kato, S; Kiyohara, H; Nakano, T; Ohkubo, Y; Ohno, T; Tran, DN | 1 |
Bryant, L; Cladd, H; Hoskin, P; Hughes, R; Lowe, G; Milner, J; Ostler, P; Rojas, A | 1 |
Jiang, W; Li, L; Liu, Y; Wu, YY; Zeng, SY; Zhong, ML | 1 |
Ke, QH; Liu, Z; Su, XY; Yang, JY; Zhang, WT; Zhou, SQ | 1 |
Gabor, S; Hackl, A; Mayer, R; Prettenhofer, U; Stranzl, H; Wurzinger, G | 1 |
Gonzalez, J; Gustafson, G; Kearney, D; Kestin, L; Martinez, A; Spencer, W; Vicini, FA | 1 |
Brenner, PC; Cross, P; Duval, PJ; Jagavkar, RS; Kooner, R; Martland, J; O'Neill, GF; Saalfeld, J; Stevens, MJ; Stricker, PD | 1 |
Lee, WR; Moughan, J; Owen, JB; Zelefsky, MJ | 1 |
Conill, C; Molla, M; Sánchez-Reyes, A; Vilalta, A | 1 |
Fujii, T; Fujisawa, M; Hiratsuka, J; Jo, Y; Takenaka, A | 1 |
Chen, SW; Liang, JA; Lin, FJ; Shiau, AC; Yang, SN; Yeh, LS | 1 |
Bownes, P; Bryant, L; de Canha, SM; Glynne Jones, R; Hoskin, PJ | 1 |
Deneufbourg, JM; Lenaerts, E; Nickers, P; Thissen, B | 1 |
Berghold, A; Kapp, DS; Kapp, KS; Lahousen, M; Oechs, A; Petru, E; Poschauko, J; Tauss, J; Winter, R | 1 |
Deneufbourg, JM; Jansen, N; Nickers, P; Thissen, B | 1 |
Maloney, KE; Moul, JW; Sevilla, DW; Tseng, TY | 1 |
Dokiya, T; Momma, T; Murai, M; Saito, S; Toya, K; Yorozu, A | 1 |
Muqit, MM; Roberts, F | 1 |
Castellanos, E; Cohn-Cedermark, G; Fowler, J; Hellström, M; Kälkner, KM; Levitt, S; Lundell, M; Nilsson, J; Nilsson, S; Ryberg, M; Wahlgren, T; Zimmerman, R | 1 |
Chang, LF; Horvath, J; Ling, SS; Peyton, W | 1 |
Edmundson, G; Gonzalez, J; Gustafson, G; Hollander, J; Martinez, A; Ohanian, N; Spencer, W; Stromberg, J; Vicini, F; Yan, Di | 1 |
Court, B; Gerbaulet, A; Haie-Meder, C; Lartigau, E; Perrin, JL; Wibault, P | 1 |
Amin, PA; Griffin, PC; Hughes, P; Levine, AM; Salazar, OM; Sewchand, WW | 1 |
Jones, RD; Robertson, AG; Symonds, RP; Thomas, R | 1 |
Bagshaw, MA; Ben-Yosef, R; Fessenden, P; Goffinet, DR; Kapp, DS; Prionas, SD | 1 |
Benson, R; Brabbins, D; Diokno, A; Edmundson, G; Garton, G; Gonzalez, J; Martinez, A; Schray, M; Stromberg, J; Zincke, H | 1 |
Brady, LW; Chalal, JA; Miyamoto, C; Sauer, R; Seegenschmiedt, MH | 1 |
Leung, S; Sexton, M | 1 |
Ardiet, JM; Ayzac, L; Barbet, N; Cenni, JL; Coquard, R; Gérard, JP; Rocher, FP; Romestaing, P; Souquet, JC | 1 |
Minsky, BD | 1 |
Bianco, J; Boulware, RJ; Greene, FL | 1 |
Ali, MM; Goplerud, DR; Howells, R; Huang, DT; Lu, JD | 1 |
Ardiet, JM; Ayzac, L; Barbet, N; Coquard, R; Gerard, JP; Romestaing, P; Roy, P; Thalabard, JC | 1 |
Coia, LR; Gaspar, LE; Graham, M; Herskovic, A; Kocha, WI; Qian, C | 1 |
Boeken Kruger, CG; Hanssens, PE; Helle, PA; Jansen, PP; Koper, PC; van Putten, WL; Wijnmaalen, A | 1 |
Bacskulin, A; Ehrhardt, M; Guthoff, R; Pau, HW; Strietzel, M; von Schwanewede, H | 1 |
McNee, SG; Paul, J; Reed, NS; Robertson, AG; Sandhu, AP; Symonds, RP | 1 |
Filho, WD; Lopes, A; Nakagawa, WT; Novaes, PE; Rossi, BM | 1 |
Budach, V; Deger, S; Dinges, S; Hinkelbein, W; Loening, SA; Roigas, J; Schnorr, D; Turk, I | 1 |
Higgins, B; Kovarik, J; Svoboda, VH | 1 |
Boehmer, D; Budach, V; Deger, S; Dietel, M; Dinges, S; Hinkelbein, W; Koswig, S; Loening, SA; Schnorr, D; Wiegel, T | 1 |
Furuta, M; Kano, Y; Tsukiyama, I | 1 |
Beauduin, M; Coppers, L; Darimont, M; de Leval, J; Deneufbourg, J; Nickers, P | 1 |
Lim, JI; Petrovich, Z | 1 |
Hiratsuka, J; Imajo, Y; Kurebayashi, J; Shimozuma, K; Sonoo, H; Yamamoto, S; Yoden, E | 1 |
Albert, A; Beauduin, M; Coppens, L; de Leval, J; Deneufbourg, JM; Nickers, P; Sabatier, J | 1 |
Austin, PA; Baghdassarian, R; Cherlow, JM; Espinoza-Ferrel, T; Ingram, JE; Londrc, A; Perley, JE; Perley, JM; Puthawala, AA; Sawyer, DE; Shanberg, AM; Syed, AM; Wachs, BH | 1 |
Agarwal, JP; Budrukkar, AN; Deshpande, DD; Dinshaw, KA; Jalali, R; Nehru, RM; Shrivastava, SK | 1 |
Ahluwalia, BD; Arnold, CD; Gaston, RC; Gold, MA; Macdurmon, GW; Mayr, NA; Montebello, JF; Parry, CK; Sonnad, JR | 1 |
Hackl, A; Hausegger, KA; Klein, GE; Lammer, J; Leitner, H; Pakisch, B; Poier, E; Poschauko, J; Stücklschweiger, G | 1 |
Bohndorf, W; Bratengeier, K; Feustel, H; Pfreundner, L; Warszawski, N | 1 |
Albuisson, E; Baillet, F; Donnarieix, D; Douchez, J; Gerard, JP; Gerbaulet, A; Giraud, B; Mazeron, JJ; Pernot, M; Rozan, R | 1 |
Calitchi, E; Dubray, B; Le Bourgeois, JP; Le Péchoux, C; Mazeron, JJ; Otmezguine, Y; Pierquin, B; Simon, JM; Thames, HD | 1 |
Bush, S; Khan, K; Stidley, C; Thompson, W | 1 |
Austin, P; Baghdassarian, R; Cherlow, J; Perley, J; Puthawala, A; Sawyer, D; Shanberg, A; Syed, AM; Tansey, L; Wachs, B | 1 |
Ackerman, N; Beale, BS; Bellah, JR; Ellison, GW; Thompson, JP | 1 |
Haubold, B; Jörling, P; Junghanns, K; Leber, K; Schmid, HU | 1 |
Thomas, LA | 1 |
Dunn, P; Kam, KC; Lambert, HE; Pickering, DG; Stewart, JS; Thomas, H | 1 |
Donnelly, BJ; McPhee, MS; Pedersen, JE; Porter, AT | 1 |
Calitchi, E; Crook, J; Le Bourgeois, JP; Mazeron, JJ; Otmezguine, Y; Pierquin, B; Simon, JM | 1 |
Kucera, H; Seifert, M; Vavra, N; Weghaupt, K | 1 |
Hahn, P; Krepart, G; Malaker, K | 1 |
Arian-Schad, K; Ebner, F; Einspieler, R; Flückiger, F; Hausegger, K; Poschauko, H | 1 |
Calitchi, E; Despretz, J; Grimard, L; Julien, M; Otmezguine, Y | 1 |
Hagenmüller, F; Ries, G; Sander, C; Sander, R; Töpfer, M | 1 |
Calitchi, E; Despretz, J; Grimard, L; Julien, M; Le Bourgeois, JP; Mazeron, JJ; Otmezguine, Y; Pierquin, B | 1 |
Rieke, H; Ulbrich, F | 1 |
Ardiet, JM; Chassard, JL; Gerard, JP; Montbarbon, JF; Papillon, J | 1 |
Astrahan, M; Cohen, D; Jepson, J; Lam, K; Langholz, B; Luxton, G; Petrovich, Z | 1 |
Bey, P; Hoffstetter, S; Luporsi, E; Pernot, M; Taghian, A | 1 |
Beorchia, A; Cereghini, M; Contento, G; Fabretto, M; Fongione, S; Guglielmi, R; Mandoliti, G; Pizzi, G | 1 |
Ali, MM; Hackler, RH; Klein, FA; Marks, SE | 1 |
Fuwa, N; Ito, Y; Morita, K; Okumura, E | 1 |
Antoci, B; Campagnutta, E; Ferrari, P; Linciano, M; Luciani, M; Pizzi, GB | 1 |
De Laroche, G; Gerard, JP; Koonsilin, L; Mornex, F; Romestaing, P | 1 |
Schmid, AP | 1 |
2 review(s) available for iridium radioisotopes and Adenocarcinoma
Article | Year |
---|---|
[Brachytherapy in prostatic adenocarcinoma].
Topics: Adenocarcinoma; Brachytherapy; Combined Modality Therapy; Gold Radioisotopes; Humans; Iodine Radioisotopes; Iridium Radioisotopes; Lymph Node Excision; Male; Prognosis; Prostatic Neoplasms; Survival Rate | 1994 |
Clinical experience with interstitial thermoradiotherapy for localized implantable pelvic tumors.
Topics: Actuarial Analysis; Adenocarcinoma; Adult; Aged; Aged, 80 and over; Brachytherapy; Carcinoma, Squamous Cell; Combined Modality Therapy; Dose-Response Relationship, Radiation; Feasibility Studies; Female; Follow-Up Studies; Humans; Hyperthermia, Induced; Iridium Radioisotopes; Male; Microwaves; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Pelvic Neoplasms; Prognosis; Radiotherapy Dosage; Remission Induction; Sarcoma; Survival Analysis; Treatment Outcome | 1993 |
20 trial(s) available for iridium radioisotopes and Adenocarcinoma
Article | Year |
---|---|
[Complications and effectiveness of treatment of patients with locally advanced prostate cancer after combined radiotherapy and radical prostatectomy with postoperative radiotherapy].
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Erectile Dysfunction; Humans; Incidence; Intraoperative Period; Iridium Radioisotopes; Male; Middle Aged; Neoplasm Staging; Postoperative Period; Prostatectomy; Prostatic Neoplasms; Radiotherapy, Adjuvant; Russia; Treatment Outcome; Urinary Incontinence | 2015 |
Favorable Preliminary Outcomes for Men With Low- and Intermediate-risk Prostate Cancer Treated With 19-Gy Single-fraction High-dose-rate Brachytherapy.
Topics: Adenocarcinoma; Adult; Aged; Brachytherapy; Follow-Up Studies; Humans; Iridium Radioisotopes; Male; Middle Aged; Neoplasm Grading; Non-Randomized Controlled Trials as Topic; Organ Size; Prostate; Prostate-Specific Antigen; Prostatic Neoplasms; Radiotherapy Dosage; Risk; Time Factors; Treatment Outcome; Ultrasonography, Interventional; Urination Disorders | 2017 |
[Concurrent chemoradiotherapy versus radiotherapy in advanced cervical carcinoma].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brachytherapy; Carboplatin; Carcinoma, Squamous Cell; Cisplatin; Cobalt Radioisotopes; Combined Modality Therapy; Female; Fluorouracil; Follow-Up Studies; Humans; Iridium Radioisotopes; Middle Aged; Neoplasm Staging; Paclitaxel; Radioisotope Teletherapy; Survival Rate; Uterine Cervical Neoplasms | 2008 |
High-dose-rate brachytherapy alone for localized prostate cancer in patients at moderate or high risk of biochemical recurrence.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Brachytherapy; Dose Fractionation, Radiation; Follow-Up Studies; Humans; Iridium Radioisotopes; Male; Middle Aged; Neoplasm Recurrence, Local; Organs at Risk; Prostate-Specific Antigen; Prostatic Neoplasms; Rectum; Urethra | 2012 |
[A randomized controlled trial of two chemotherapy regimens (paclitaxel liposome combined with platinum and paclitaxel combined with platinum) in concurrent chemoradiotherapy for cervical carcinoma].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Carboplatin; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Cobalt Radioisotopes; Exanthema; Female; Follow-Up Studies; Gastrointestinal Diseases; Humans; Iridium Radioisotopes; Liposomes; Middle Aged; Neoplasm Staging; Paclitaxel; Remission Induction; Survival Rate; Uterine Cervical Neoplasms | 2011 |
[Analysis of the initial efficacy of nedaplatin combined with megestrol in concurrent chemoradiotherapy for advanced cervical cancer].
Topics: Adenocarcinoma; Adult; Alopecia; Anemia; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Chemoradiotherapy; Diarrhea; Female; Follow-Up Studies; Humans; Iridium Radioisotopes; Leukopenia; Megestrol; Middle Aged; Neoplasm Staging; Organoplatinum Compounds; Particle Accelerators; Radiotherapy, High-Energy; Remission Induction; Survival Rate; Thrombocytopenia; Uterine Cervical Neoplasms | 2011 |
Conformal high dose rate brachytherapy improves biochemical control and cause specific survival in patients with prostate cancer and poor prognostic factors.
Topics: Actuarial Analysis; Adenocarcinoma; Aged; Aged, 80 and over; Brachytherapy; Disease-Free Survival; Humans; Iridium Radioisotopes; Male; Middle Aged; Multivariate Analysis; Prognosis; Prospective Studies; Prostate-Specific Antigen; Prostatic Neoplasms; Radiotherapy Dosage; Radiotherapy, Conformal; Survival Rate | 2003 |
High-dose-rate iridium-192 afterloading therapy combined with external beam radiotherapy for T1c-T3bN0M0 prostate cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Biomarkers, Tumor; Brachytherapy; Combined Modality Therapy; Cystitis; Disease-Free Survival; Dose Fractionation, Radiation; Humans; Iridium Radioisotopes; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Proteins; Neoplasm Recurrence, Local; Proctitis; Prostate-Specific Antigen; Prostatic Neoplasms; Radiation Injuries; Radiotherapy, High-Energy; Treatment Outcome | 2004 |
Does inverse planning applied to Iridium192 high dose rate prostate brachytherapy improve the optimization of the dose afforded by the Paris system?
Topics: Adenocarcinoma; Brachytherapy; Dose Fractionation, Radiation; Humans; Imaging, Three-Dimensional; Iridium Radioisotopes; Male; Patient Care Planning; Prostatic Neoplasms; Radiation Injuries; Radiometry; Tomography, X-Ray Computed; Treatment Outcome | 2005 |
Clinical outcome in patients with prostate cancer treated with external beam radiotherapy and high dose-rate iridium 192 brachytherapy boost: a 6-year follow-up.
Topics: Adenocarcinoma; Aged; Brachytherapy; Disease-Free Survival; Humans; Iridium Radioisotopes; Male; Middle Aged; Neoplasm Staging; Prostatic Neoplasms; Radiotherapy Dosage; Radiotherapy, Conformal; Treatment Outcome | 2007 |
Ultrasound-guided high dose rate conformal brachytherapy boost in prostate cancer: treatment description and preliminary results of a phase I/II clinical trial.
Topics: Adenocarcinoma; Aged; Biomarkers, Tumor; Brachytherapy; Follow-Up Studies; Humans; Iridium Radioisotopes; Male; Middle Aged; Neoplasm Staging; Prospective Studies; Prostate-Specific Antigen; Prostatic Neoplasms; Radiotherapy Dosage; Ultrasonography, Interventional | 1995 |
Thermometry of interstitial hyperthermia given as an adjuvant to brachytherapy for the treatment of carcinoma of the prostate.
Topics: Adenocarcinoma; Aged; Brachytherapy; Combined Modality Therapy; Hot Temperature; Humans; Hyperthermia, Induced; Iridium Radioisotopes; Male; Middle Aged; Neoplasm Recurrence, Local; Prostatic Neoplasms; Prostheses and Implants; Retrospective Studies; Thermometers | 1994 |
Improved local control and survival for surgically staged patients with locally advanced prostate cancer treated with up-front low dose rate iridium-192 prostate implantation and external beam irradiation.
Topics: Adenocarcinoma; Adult; Aged; Brachytherapy; Follow-Up Studies; Humans; Iridium Radioisotopes; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prospective Studies; Prostatic Neoplasms; Survival Analysis; Survival Rate | 1994 |
Clinical experience with interstitial thermoradiotherapy for localized implantable pelvic tumors.
Topics: Actuarial Analysis; Adenocarcinoma; Adult; Aged; Aged, 80 and over; Brachytherapy; Carcinoma, Squamous Cell; Combined Modality Therapy; Dose-Response Relationship, Radiation; Feasibility Studies; Female; Follow-Up Studies; Humans; Hyperthermia, Induced; Iridium Radioisotopes; Male; Microwaves; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Pelvic Neoplasms; Prognosis; Radiotherapy Dosage; Remission Induction; Sarcoma; Survival Analysis; Treatment Outcome | 1993 |
A phase I/II study of external beam radiation, brachytherapy and concurrent chemotherapy in localized cancer of the esophagus (RTOG 92-07): preliminary toxicity report.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Esophageal Fistula; Esophageal Neoplasms; Feasibility Studies; Female; Fluorouracil; Humans; Iridium Radioisotopes; Male; Middle Aged; Neoplasm Staging; Prospective Studies; Radiotherapy Dosage; Radiotherapy, High-Energy; Treatment Failure | 1997 |
High-dose rate iridium192 afterloading therapy in combination with external beam irradiation for localized prostate cancer.
Topics: Adenocarcinoma; Aged; Brachytherapy; Carcinoma in Situ; Combined Modality Therapy; Follow-Up Studies; Humans; Iridium Radioisotopes; Male; Middle Aged; Prostatic Neoplasms; Radiation Dosage; Treatment Outcome | 1997 |
High-dose rate interstitial with external beam irradiation for localized prostate cancer--results of a prospective trial.
Topics: Adenocarcinoma; Aged; Biopsy; Brachytherapy; Colitis, Ulcerative; Colostomy; Diabetes Complications; Feasibility Studies; Fistula; Follow-Up Studies; Humans; Iridium Radioisotopes; Laparoscopy; Lymph Node Excision; Lymph Nodes; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prospective Studies; Prostate-Specific Antigen; Prostatic Neoplasms; Radiation Injuries; Radiopharmaceuticals; Radiotherapy Dosage; Rectal Fistula; Risk Factors; Urethral Diseases | 1998 |
Interstitial iridium-192 for bladder cancer (a multicentric survey: 205 patients).
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Brachytherapy; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Combined Modality Therapy; Female; Follow-Up Studies; France; Humans; Iridium Radioisotopes; Male; Middle Aged; Neoplasm Recurrence, Local; Retrospective Studies; Survival Rate; Urinary Bladder Neoplasms | 1992 |
[Palliative treatment of malignant stenoses of the esophagus and cardia: laser therapy versus laser + high-dose-rate Iridium 192 afterloading therapy. A prospective randomized study].
Topics: Adenocarcinoma; Aged; Carcinoma, Squamous Cell; Cardia; Clinical Trials as Topic; Combined Modality Therapy; Esophageal Neoplasms; Esophageal Stenosis; Female; Humans; Iridium Radioisotopes; Laser Therapy; Male; Palliative Care; Prospective Studies; Radiotherapy Dosage; Random Allocation; Stomach Neoplasms | 1989 |
Interstitial microwave hyperthermia combined with iridium-192 radiotherapy for recurrent tumors.
Topics: Actuarial Analysis; Adenocarcinoma; Adult; Aged; Aged, 80 and over; Brachytherapy; Breast Neoplasms; Carcinoma, Squamous Cell; Clinical Trials as Topic; Combined Modality Therapy; Diathermy; Female; Head and Neck Neoplasms; Humans; Iridium Radioisotopes; Male; Microwaves; Middle Aged | 1989 |
69 other study(ies) available for iridium radioisotopes and Adenocarcinoma
Article | Year |
---|---|
Outcomes and treatments of IB1 cervical cancers with high recurrence risk: A 13 years' experience.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Carboplatin; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Etoposide; Female; Humans; Iridium Radioisotopes; Kaplan-Meier Estimate; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Prognosis; Radiotherapy, Adjuvant; Recurrence; Retrospective Studies; Risk; Treatment Outcome; Uterine Cervical Neoplasms | 2018 |
[Comparison of the efficacy of three neoadjuvant therapy regimens on locally advanced cervical cancer].
Topics: Adenocarcinoma; Adult; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Chemoradiotherapy, Adjuvant; Chemotherapy, Adjuvant; Female; Humans; Hysterectomy; Iridium Radioisotopes; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Paclitaxel; Preoperative Period; Radiotherapy, Adjuvant; Retrospective Studies; Serpins; Treatment Outcome; Uterine Cervical Neoplasms | 2013 |
Organ preservation in rectal adenocarcinoma (T1) T2-T3 Nx M0. Historical overview of the Lyon Sud - nice experience using contact x-ray brachytherapy and external beam radiotherapy for 120 patients.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Brachytherapy; Clinical Protocols; Combined Modality Therapy; Dose Fractionation, Radiation; Female; France; Humans; Intestinal Polyps; Iridium Radioisotopes; Male; Organ Sparing Treatments; Radiotherapy, Conformal; Rectal Neoplasms | 2015 |
CT-guided high-dose-rate brachytherapy in the interdisciplinary treatment of patients with liver metastases of pancreatic cancer.
Topics: Adenocarcinoma; Adult; Aged; Brachytherapy; Chemotherapy, Adjuvant; Disease Progression; Disease-Free Survival; Female; Humans; Iridium Radioisotopes; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Pancreatic Neoplasms; Radiology, Interventional; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Image-Guided; Retrospective Studies; Survival Rate; Tomography, X-Ray Computed | 2015 |
Effect of rectal enemas on rectal dosimetric parameters during high-dose-rate vaginal cuff brachytherapy: A prospective trial.
Topics: Adenocarcinoma; Adult; Aged; Brachytherapy; Carcinoma, Squamous Cell; Dose Fractionation, Radiation; Endometrial Neoplasms; Enema; Female; Humans; Imaging, Three-Dimensional; Iridium Radioisotopes; Middle Aged; Neoplasm Staging; Organ Size; Prospective Studies; Radiometry; Radiotherapy Dosage; Radiotherapy, Adjuvant; Radiotherapy, High-Energy; Rectum; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2016 |
External beam radiation therapy followed by interstitial radiotherapy with iridium-192 for solitary bladder tumours: results of 111 treated patients.
Topics: Adenocarcinoma; Aged; Brachytherapy; Carcinoma; Carcinoma, Squamous Cell; Disease-Free Survival; Female; Follow-Up Studies; Humans; Hydronephrosis; Ileus; Iridium Radioisotopes; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Radiotherapy, Adjuvant; Retrospective Studies; Survival Rate; Treatment Outcome; Urinary Bladder Neoplasms; Urinary Incontinence, Urge | 2009 |
Geometrical sparing factors for the rectum and bladder in the prediction of grade 2 and higher complications after high-dose-rate brachytherapy for cervical cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Brachytherapy; Carcinoma, Squamous Cell; Female; Humans; Iridium Radioisotopes; Middle Aged; Radiation Injuries; Radiotherapy Dosage; Rectum; Reference Values; Regression Analysis; Risk Factors; Urinary Bladder; Uterine Cervical Neoplasms | 2009 |
Factors for predicting rectal dose of high-dose-rate intracavitary brachytherapy after pelvic irradiation in patients with cervical cancer: a retrospective study with radiography-based dosimetry.
Topics: Adenocarcinoma; Brachytherapy; Carcinoma, Squamous Cell; Female; Humans; Iridium Radioisotopes; Middle Aged; Proctitis; Radiation Injuries; Radiography; Radiotherapy Dosage; Radiotherapy, Intensity-Modulated; Rectum; Regression Analysis; Relative Biological Effectiveness; Retrospective Studies; Uterine Cervical Neoplasms | 2010 |
[Comparison of uterine artery chemoembolization and internal iliac arterial infusion chemotherapy for the combining treatment for women with locally advanced cervical cancer].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Carboplatin; Carcinoma, Squamous Cell; Chemoembolization, Therapeutic; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Hysterectomy; Iliac Artery; Infusions, Intra-Arterial; Iridium Radioisotopes; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm, Residual; Remission Induction; Retrospective Studies; Tumor Burden; Uterine Artery; Uterine Cervical Neoplasms; Young Adult | 2009 |
[Surgical intervention for the central recurrence or persistent local lesion of uterine cervical carcinoma following full-dose radiotherapy].
Topics: Adenocarcinoma; Adult; Aged; Brachytherapy; Carcinoma, Squamous Cell; Cervix Uteri; Cesium Radioisotopes; Female; Follow-Up Studies; Humans; Hysterectomy; Iridium Radioisotopes; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Radiotherapy Dosage; Radiotherapy, High-Energy; Retrospective Studies; Survival Rate; Uterine Cervical Neoplasms; Young Adult | 2010 |
CT-based 3D dose-volume parameter of the rectum and late rectal complication in patients with cervical cancer treated with high-dose-rate intracavitary brachytherapy.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Brachytherapy; Carcinoma, Squamous Cell; Dose-Response Relationship, Radiation; Female; Humans; Imaging, Three-Dimensional; Iridium Radioisotopes; Middle Aged; Organ Size; Radiation Injuries; Radiation Protection; Radiometry; Radiotherapy Dosage; Radiotherapy, High-Energy; Rectal Diseases; Rectum; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2010 |
Fractionated intraluminal HDR 192Ir brachytherapy as palliative treatment in patients with endobronchial metastases from non-bronchogenic primaries.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Brachytherapy; Breast Neoplasms; Bronchial Neoplasms; Carcinoma, Renal Cell; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Dose Fractionation, Radiation; Female; Follow-Up Studies; Humans; Iridium Radioisotopes; Kidney Neoplasms; Male; Middle Aged; Palliative Care; Prostatic Neoplasms; Radiotherapy Dosage; Rectal Neoplasms; Sigmoid Neoplasms; Time Factors; Tongue Neoplasms; Tonsillar Neoplasms; Urinary Bladder Neoplasms; Uterine Neoplasms | 2002 |
Treatment of localized prostate cancer using a combination of high dose rate Iridium-192 brachytherapy and external beam irradiation: initial Australian experience.
Topics: Adenocarcinoma; Adult; Aged; Brachytherapy; Erectile Dysfunction; Follow-Up Studies; Humans; Iridium Radioisotopes; Male; Middle Aged; Prostate-Specific Antigen; Prostatic Neoplasms; Radiotherapy Dosage; Radiotherapy, Conformal; Retrospective Studies; Treatment Outcome | 2003 |
The 1999 patterns of care study of radiotherapy in localized prostate carcinoma: a comprehensive survey of prostate brachytherapy in the United States.
Topics: Adenocarcinoma; Aged; Androgen Antagonists; Brachytherapy; Combined Modality Therapy; Humans; Iodine Radioisotopes; Iridium Radioisotopes; Male; Middle Aged; Palladium; Prostatic Neoplasms; Radiotherapy Dosage; Radiotherapy, Adjuvant; Radiotherapy, Conformal | 2003 |
Brachytherapy with 192Ir as treatment of carcinoma of the tarsal structure of the eyelid.
Topics: Adenocarcinoma; Aged; Brachytherapy; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Eyelid Neoplasms; Female; Follow-Up Studies; Humans; Iridium Radioisotopes; Male; Middle Aged | 2004 |
Comparative study of reference points by dosimetric analyses for late complications after uniform external radiotherapy and high-dose-rate brachytherapy for cervical cancer.
Topics: Adenocarcinoma; Brachytherapy; Carcinoma, Squamous Cell; Dose-Response Relationship, Radiation; Female; Humans; Iridium Radioisotopes; Logistic Models; Radiation Injuries; Radiotherapy Dosage; Rectum; Survival Analysis; Time Factors; Urinary Bladder; Uterine Cervical Neoplasms | 2004 |
High dose rate afterloading intraluminal brachytherapy for advanced inoperable rectal carcinoma.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Brachytherapy; Female; Follow-Up Studies; Humans; Iridium Radioisotopes; Male; Middle Aged; Palliative Care; Radiotherapy Dosage; Rectal Neoplasms; Retrospective Studies; Risk Assessment; Survival Analysis; Treatment Outcome | 2004 |
Analysis of the prognostic impact of tumor embolization before definitive radiotherapy for cervical carcinoma.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Analysis of Variance; Anemia; Carcinoma, Squamous Cell; Disease-Free Survival; Embolization, Therapeutic; Erythrocyte Transfusion; Female; Humans; Iridium Radioisotopes; Middle Aged; Prognosis; Retrospective Studies; Uterine Cervical Neoplasms; Uterine Hemorrhage | 2005 |
192Ir or 125I prostate brachytherapy as a boost to external beam radiotherapy in locally advanced prostatic cancer: a dosimetric point of view.
Topics: Adenocarcinoma; Brachytherapy; Combined Modality Therapy; Dose-Response Relationship, Radiation; Humans; Iodine Radioisotopes; Iridium Radioisotopes; Male; Prostatic Neoplasms; Radiotherapy Dosage; Radiotherapy, Computer-Assisted | 2006 |
Prostatic carcinosarcoma 15 years after combined external beam radiation and brachytherapy for prostatic adenocarcinoma: a case report.
Topics: Adenocarcinoma; Aged; Biopsy, Needle; Brachytherapy; Carcinosarcoma; Combined Modality Therapy; Follow-Up Studies; Humans; Immunohistochemistry; Iridium Radioisotopes; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Multiple Primary; Neoplasms, Radiation-Induced; Pelvic Exenteration; Prostate-Specific Antigen; Prostatic Neoplasms; Rectal Neoplasms; Time Factors; Treatment Outcome | 2006 |
Three-year results of treatment for prostate cancer with low-dose rate temporary iridium-192 brachytherapy.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Brachytherapy; Follow-Up Studies; Humans; Iridium Radioisotopes; Male; Middle Aged; Neoplasm Staging; Prostatic Neoplasms; Retrospective Studies; Treatment Outcome | 2006 |
In regards to Conill et al.: Brachytherapy with 192Ir as treatment of carcinoma of the tarsal structure of the eyelid (Int J Radiat Oncol Bio Phys 2004;59:1326-1329).
Topics: Adenocarcinoma; Brachytherapy; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Eyelid Neoplasms; Humans; Iridium Radioisotopes | 2006 |
High dose rate afterloading intraluminal brachytherapy in malignant airway obstruction of lung cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Airway Obstruction; Brachytherapy; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Humans; Iridium Radioisotopes; Lung Neoplasms; Male; Middle Aged; Palliative Care; Radiotherapy Dosage; Retrospective Studies; Survival Rate | 1994 |
Pelvic mass: CT-guided interstitial catheter implantation with high-dose-rate remote afterloader.
Topics: Adenocarcinoma; Aged; Bone Neoplasms; Brachytherapy; Female; Humans; Ilium; Iridium Radioisotopes; Neoplasms, Unknown Primary; Radiotherapy Dosage; Tomography, X-Ray Computed | 1994 |
Changes in the radiation treatment of cancer of the anus in Glasgow.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Anus Neoplasms; Brachytherapy; Carcinoma, Squamous Cell; Cesium Radioisotopes; Female; Humans; Iridium Radioisotopes; Male; Middle Aged; Radium; Scotland | 1993 |
Radical radiation therapy for carcinoma of the vagina--impact of treatment modalities on outcome: Peter MacCallum Cancer Institute experience 1970-1990.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Australia; Brachytherapy; Carcinoma, Squamous Cell; Female; Humans; Iridium Radioisotopes; Middle Aged; Retrospective Studies; Survival Rate; Vaginal Neoplasms | 1993 |
Endocavitary irradiation for early rectal carcinomas T1 (T2). A series of 101 patients treated with the Papillon's technique.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Brachytherapy; Female; Gastrointestinal Hemorrhage; Humans; Iridium Radioisotopes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Rectal Neoplasms; Rectum; Retrospective Studies; Survival Analysis; Treatment Failure; Ultrasonography | 1996 |
Conservative management of early rectal cancer.
Topics: Adenocarcinoma; Brachytherapy; Combined Modality Therapy; Humans; Iridium Radioisotopes; Neoplasm Staging; Rectal Neoplasms; Treatment Failure | 1996 |
Role of esophagogastroscopy in application and follow-up of high-dose-rate brachytherapy (HDRB) for treatment of esophageal carcinoma.
Topics: Adenocarcinoma; Brachytherapy; Carcinoma, Squamous Cell; Catheterization; Deglutition; Deglutition Disorders; Enteral Nutrition; Esophageal Diseases; Esophageal Fistula; Esophageal Neoplasms; Esophagogastric Junction; Esophagoscopy; Esophagus; Female; Follow-Up Studies; Gastroscopy; Gastrostomy; Hemorrhage; Humans; Iridium Radioisotopes; Male; Radiotherapy Dosage; Remission Induction; Survival Rate | 1995 |
Radiation alone for carcinoma of the vagina: variation in response related to the location of the primary tumor.
Topics: Actuarial Analysis; Adenocarcinoma; Aged; Brachytherapy; Carcinoma; Carcinoma, Squamous Cell; Female; Follow-Up Studies; Humans; Iodine Radioisotopes; Iridium Radioisotopes; Leiomyosarcoma; Melanoma; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Radiotherapy Dosage; Remission Induction; Retrospective Studies; Salvage Therapy; Survival Rate; Treatment Failure; Vaginal Neoplasms | 1996 |
Combined curative radiation therapy alone in (T1) T2-3 rectal adenocarcinoma: a pilot study of 29 patients.
Topics: Adenocarcinoma; Aged; Brachytherapy; Female; Follow-Up Studies; Humans; Iridium Radioisotopes; Male; Pilot Projects; Radiotherapy Dosage; Radiotherapy, High-Energy; Rectal Neoplasms; Retrospective Studies; Survival Rate; Time Factors; X-Ray Therapy | 1996 |
Muscle invasive bladder cancer treated by transurethral resection, followed by external beam radiation and interstitial iridium-192.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Brachytherapy; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Combined Modality Therapy; Female; Humans; Iridium Radioisotopes; Male; Middle Aged; Urinary Bladder Neoplasms | 1997 |
An adjuvant afterloading brachytherapy device for use after orbital exenteration in patients with orbital malignancies.
Topics: Adenocarcinoma; Adult; Aged; Brachytherapy; Carcinoma, Adenoid Cystic; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cobalt Radioisotopes; Eyelid Neoplasms; Female; Humans; Iridium Radioisotopes; Lacrimal Apparatus Diseases; Male; Maxillary Sinus Neoplasms; Middle Aged; Orbit Evisceration; Orbital Neoplasms; Tomography, X-Ray Computed; Treatment Outcome | 1996 |
Interstitial iridium-192 implantation combined with external radiotherapy in anal cancer: ten years experience.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Anus Neoplasms; Brachytherapy; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Combined Modality Therapy; Female; Humans; Iridium Radioisotopes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Proportional Hazards Models; Treatment Failure | 1998 |
Radiation and chemotherapy instead of surgery for low infiltrative rectal adenocarcinoma: a prospective trial.
Topics: Abdomen; Adenocarcinoma; Adjuvants, Immunologic; Anal Canal; Antidotes; Antimetabolites, Antineoplastic; Brachytherapy; Cesium Radioisotopes; Disease-Free Survival; Female; Fluorouracil; Follow-Up Studies; Humans; Iridium Radioisotopes; Leucovorin; Levamisole; Male; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Peritoneum; Prospective Studies; Radiopharmaceuticals; Radiotherapy Dosage; Rectal Neoplasms; Remission Induction; Survival Rate; Treatment Outcome; Treatment Refusal | 1998 |
Conservative treatment of anorectal tumors.
Topics: Adenocarcinoma; Aged; Anus Neoplasms; Brachytherapy; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Disease-Free Survival; Female; Humans; Iridium Radioisotopes; Male; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Radiography; Rectal Neoplasms; Survival Rate; Time Factors | 1998 |
Uniformity of biological effect in high-dose rate stepping source brachytherapy: an in vitro study.
Topics: Adenocarcinoma; Brachytherapy; Colonic Neoplasms; Dose-Response Relationship, Radiation; Humans; Iridium Radioisotopes; Lung Neoplasms; Radiotherapy Dosage; Relative Biological Effectiveness | 1999 |
Feasibility study combining low dose rate (192)Ir brachytherapy and external beam radiotherapy aiming at delivering 80-85 Gy to prostatic adenocarcinoma.
Topics: Adenocarcinoma; Aged; Analysis of Variance; Antineoplastic Agents, Hormonal; Brachytherapy; Chemotherapy, Adjuvant; Chi-Square Distribution; Feasibility Studies; Follow-Up Studies; Humans; Intraoperative Care; Iridium Radioisotopes; Male; Middle Aged; Neoplasm Recurrence, Local; Pelvic Bones; Prostate; Prostate-Specific Antigen; Prostatic Neoplasms; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy, Conformal; Rectum; Seminal Vesicles; Ultrasonography, Interventional; Urethra | 2000 |
Radioactive plaque therapy for metastatic choroidal carcinoma.
Topics: Adenocarcinoma; Adult; Aged; Brachytherapy; Breast Neoplasms; Carcinoma, Ductal, Breast; Choroid Neoplasms; Female; Humans; Iodine Radioisotopes; Iridium Radioisotopes; Male; Middle Aged; Optic Atrophy; Optic Nerve; Pancreatic Neoplasms; Radiation Injuries; Retina; Retrospective Studies; Visual Acuity | 2000 |
Interstitial brachytherapy for recurrent breast cancer using a high dose rate Ir-192 remote afterloading system: a report of two cases.
Topics: Adenocarcinoma; Adenocarcinoma, Scirrhous; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Brachytherapy; Breast Neoplasms; Female; Humans; Iridium Radioisotopes; Mastectomy; Neoplasm Recurrence, Local; Neoplasm Staging; Patient Selection; Radiotherapy, Adjuvant; Tomography, X-Ray Computed; Treatment Outcome | 2000 |
PSA kinetics after external beam radiotherapy alone or combined with an iridium brachytherapy boost to deliver 85 grays to prostatic adenocarcinoma.
Topics: Adenocarcinoma; Aged; Brachytherapy; Cohort Studies; Data Interpretation, Statistical; Follow-Up Studies; Humans; Immunoenzyme Techniques; Iridium Radioisotopes; Kinetics; Male; Middle Aged; Prognosis; Proportional Hazards Models; Prostate-Specific Antigen; Prostatic Neoplasms; Radiotherapy Dosage; Retrospective Studies; Time Factors | 2001 |
Long-term results of treatment for prostate carcinoma by staging pelvic lymph node dissection and definitive irradiation using low-dose rate temporary iridium-192 interstitial implant and external beam radiotherapy.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Brachytherapy; Humans; Iridium Radioisotopes; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Proportional Hazards Models; Prostatectomy; Prostatic Neoplasms; Radiotherapy Dosage; Radiotherapy, High-Energy; Survival Analysis | 2001 |
Transperineal low-dose rate iridium-192 interstitial brachytherapy in cervical carcinoma stage IIB.
Topics: Adenocarcinoma; Adult; Age Factors; Aged; Brachytherapy; Carcinoma, Squamous Cell; Cobalt Radioisotopes; Disease-Free Survival; Female; Follow-Up Studies; Humans; Iridium Radioisotopes; Middle Aged; Particle Accelerators; Prognosis; Radiotherapy Dosage; Survival Analysis; Time Factors; Uterine Cervical Neoplasms | 2001 |
Pitfalls of radiation survey after brachytherapy implant removal preceding Tl-201 study.
Topics: Abdomen; Adenocarcinoma; Brachytherapy; Endometrial Neoplasms; Female; Humans; Intestinal Obstruction; Iridium Radioisotopes; Metabolic Clearance Rate; Middle Aged; Models, Biological; Myocardium; Radiation Protection; Radionuclide Imaging; Thallium; Whole-Body Counting | 2002 |
[Metallic mesh endoprosthesis and intraluminal high dose rate 192Ir brachytherapy in the palliative treatment of malignant bile duct obstruction. Initial results].
Topics: Adenocarcinoma; Adult; Aged; Bile Duct Neoplasms; Brachytherapy; Cholestasis; Combined Modality Therapy; Female; Gallbladder Neoplasms; Humans; Iridium Radioisotopes; Male; Middle Aged; Palliative Care; Stents | 1992 |
Combined isodose curves of high-dose rate interstitial brachytherapy with external-beam radiation therapy in pancreatic carcinoma.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Chemotherapy, Adjuvant; Combined Modality Therapy; Fluorouracil; Humans; Iridium Radioisotopes; Leucovorin; Palliative Care; Pancreatic Neoplasms; Radiotherapy Dosage; Radiotherapy, High-Energy; Time Factors; Tomography, X-Ray Computed | 1992 |
Time factors in breast carcinoma: influence of delay between external irradiation and brachytherapy.
Topics: Adenocarcinoma; Brachytherapy; Breast Neoplasms; Cobalt Radioisotopes; Female; Humans; Iridium Radioisotopes; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Proportional Hazards Models; Radiotherapy Dosage; Retrospective Studies; Time Factors; Treatment Failure | 1992 |
Transperineal percutaneous iridium-192 interstitial template implant of the prostate: results and complications in 321 patients.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Brachytherapy; Combined Modality Therapy; Humans; Iridium Radioisotopes; Lymph Node Excision; Male; Middle Aged; Prostatic Neoplasms; Retrospective Studies; Survival Analysis; Survival Rate | 1992 |
Temporary iridium-192 implant in the management of carcinoma of the prostate.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Brachytherapy; Humans; Iridium Radioisotopes; Male; Middle Aged; Prostatic Neoplasms; Survival Analysis; Treatment Outcome | 1992 |
192iridium brachytherapy, using an intracavitary afterload device, for treatment of intranasal neoplasms in dogs.
Topics: Adenocarcinoma; Animals; Brachytherapy; Chondrosarcoma; Combined Modality Therapy; Dog Diseases; Dogs; Iridium Radioisotopes; Neoplasm Recurrence, Local; Nose Neoplasms; Osteosarcoma; Radiotherapy Planning, Computer-Assisted; Treatment Outcome | 1992 |
[Improved treatment results in advanced gallbladder and bile duct cancer by postoperative combined radiotherapy].
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Bile Duct Neoplasms; Brachytherapy; Carcinoma; Cholecystectomy; Combined Modality Therapy; Female; Follow-Up Studies; Gallbladder Neoplasms; Humans; Iridium Radioisotopes; Male; Middle Aged; Particle Accelerators; Postoperative Complications; Radiotherapy Dosage; Survival Rate | 1992 |
Intraluminal radiation therapy per endoprosthesis: a case study.
Topics: Adenocarcinoma; Bile Duct Neoplasms; Cholangiography; Cholangiopancreatography, Endoscopic Retrograde; Endoscopy, Digestive System; Female; Humans; Iridium Radioisotopes; Middle Aged; Palliative Care; Stents | 1991 |
Treating the vaginal vault in carcinoma of the endometrium using the Buchler afterloading system.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Brachytherapy; Endometrial Neoplasms; Female; Humans; Iridium Radioisotopes; Middle Aged; Radiotherapy Dosage; Retrospective Studies; Vagina | 1991 |
Iridium-192 brachytherapy in the treatment of cancer of the prostate.
Topics: Adenocarcinoma; Aged; Brachytherapy; Humans; Iridium Radioisotopes; Lymphatic Metastasis; Male; Middle Aged; Prostatic Neoplasms; Radiography | 1991 |
Influence of dose rate on local control of breast carcinoma treated by external beam irradiation plus iridium 192 implant.
Topics: Adenocarcinoma; Adult; Aged; Brachytherapy; Breast Neoplasms; Female; Humans; Iridium Radioisotopes; Middle Aged; Radiotherapy; Radiotherapy Dosage | 1991 |
[Radiotherapy of primary vaginal carcinoma and effects of histological and clinical factors on the prognosis].
Topics: Adenocarcinoma; Adult; Age Factors; Aged; Aged, 80 and over; Brachytherapy; Carcinoma, Squamous Cell; Cobalt Radioisotopes; Female; Humans; Iridium Radioisotopes; Middle Aged; Prognosis; Radioisotope Teletherapy; Radiotherapy Dosage; Retrospective Studies; Vagina; Vaginal Neoplasms | 1991 |
Carcinoma of female urethra. Manitoba experience: 1958-1987.
Topics: Adenocarcinoma; Adult; Aged; Brachytherapy; Carcinoma; Carcinoma in Situ; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Female; Humans; Iridium Radioisotopes; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Radiotherapy Dosage; Urethral Neoplasms | 1991 |
[Value of magnetic resonance tomography after primary irradiation of carcinoma of the cervix uteri: evaluation of therapeutic success and follow-up].
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Brachytherapy; Carcinoma, Squamous Cell; Female; Follow-Up Studies; Humans; Iridium Radioisotopes; Magnetic Resonance Imaging; Middle Aged; Radiotherapy Dosage; Time Factors; Uterine Cervical Neoplasms | 1991 |
Conservative management of tumors of the rectum by radiotherapy and local excision.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Brachytherapy; Clinical Protocols; Combined Modality Therapy; Follow-Up Studies; Humans; Iridium Radioisotopes; Methods; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Rectal Neoplasms | 1990 |
A new combined approach in the conservative management of rectal cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Brachytherapy; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Iridium Radioisotopes; Male; Middle Aged; Particle Accelerators; Prognosis; Radiotherapy, High-Energy; Rectal Neoplasms | 1989 |
[High-frequency jet ventilation through a modified stomach tube in endobronchial 192 Iridium irradiation].
Topics: Adenocarcinoma; Aged; Brachytherapy; Bronchoscopes; Carbon Dioxide; Combined Modality Therapy; Female; Gastrostomy; High-Frequency Jet Ventilation; Humans; Iridium Radioisotopes; Lung Neoplasms; Oxygen; Pneumonectomy | 1989 |
Interstitial curietherapy in the conservative treatment of anal and rectal cancers.
Topics: Adenocarcinoma; Anus Neoplasms; Brachytherapy; Carcinoma, Squamous Cell; Humans; Iridium Radioisotopes; Rectal Neoplasms; Survival Rate | 1989 |
Radiation therapy alone for medically inoperable patients with adenocarcinoma of the endometrium.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Brachytherapy; Cesium Radioisotopes; Female; Humans; Iridium Radioisotopes; Middle Aged; Prognosis; Uterine Neoplasms | 1988 |
[Carcinoma of the female urethra. A clinical case report].
Topics: Adenocarcinoma; Adult; Brachytherapy; Catheterization; Equipment Design; Female; Follow-Up Studies; Humans; Iridium Radioisotopes; Lymphatic Metastasis; Urethral Neoplasms | 1988 |
Bilateral pelvic lymphadenectomy, iridium 192 template, and external beam therapy for localized prostatic carcinoma: complications and results.
Topics: Adenocarcinoma; Aged; Brachytherapy; Combined Modality Therapy; Humans; Iridium Radioisotopes; Lymph Node Excision; Male; Middle Aged; Pelvis; Postoperative Complications; Proctitis; Prostatic Neoplasms; Radiation Injuries; Radiotherapy Dosage | 1988 |
[Intraluminal irradiation in endobronchial carcinoma using an 192iridium thin wire].
Topics: Adenocarcinoma; Adult; Brachytherapy; Carcinoma, Bronchogenic; Carcinoma, Squamous Cell; Female; Humans; Iridium Radioisotopes; Lung Neoplasms; Male; Middle Aged | 1988 |
[Adenocarcinoma of the female urethra].
Topics: Adenocarcinoma; Adult; Brachytherapy; Female; Humans; Iridium Radioisotopes; Radiotherapy Dosage; Urethra; Urethral Neoplasms | 1988 |
Curative treatment of carcinoma of the prostate with an association of external irradiation, iridium implant and lymphadenectomy.
Topics: Adenocarcinoma; Aged; Brachytherapy; Humans; Iridium Radioisotopes; Lymph Node Excision; Male; Prognosis; Prostatic Neoplasms | 1987 |
[Interstitial brachytherapy using 192-iridium in locally recurring tumors].
Topics: Adenocarcinoma; Adult; Aged; Anus Neoplasms; Brachytherapy; Carcinoma, Squamous Cell; Female; Head and Neck Neoplasms; Humans; Iridium Radioisotopes; Male; Middle Aged; Neoplasm Recurrence, Local; Rectal Neoplasms | 1987 |